The primary therapeutic use of this combination medication is to provide short-term symptomatic assistance for conditions associated with acute or disruptive episodes, such as the common cold or influenza. It is generally used for managing the key symptoms that interfere with functional stability during periods of heightened distress.

The medication is commonly used to help manage symptoms related to physical discomfort and systemic imbalance, including fever, headaches, generalized body aches, and nasal congestion. By addressing these acute manifestations, it provides support that helps ease the overall symptom load and assists the patient during difficult episodes.

“This approach offers symptomatic relief that helps patients cope more steadily with symptom fluctuations.”

It is applied in contexts marked by symptoms that create noticeable physiological strain, and is relevant for easing manifestations related to sinus pressure and supporting breathing comfort. This combined action supports general well-being and helps improve day-to-day comfort during symptomatic phases.

Quick Fact: Relief for Key Cold Symptoms
Systemic Symptoms	Fever, Headache, Generalized aches
Respiratory Symptoms	Nasal congestion, Sinus pressure
Overall Benefit	Supportive symptomatic relief

Regulatory References

1. DailyMed (NIH) Product Label for Acetaminophen and Phenylephrine

Official Population Eligibility Status

Lemsip Blackcurrant is officially sanctioned for use by adults and adolescents aged 16 years and over. Regulatory documents define strict population restrictions and absolute exclusions, primarily related to the product’s two active ingredients, Paracetamol and Phenylephrine.

Eligibility Status	Restricted Groups (Based on Regulatory Labeling)
Contraindicated (Must Not Use)	Patients with severe coronary heart disease, hypertension, hyperthyroidism, phaeochromocytoma, closed-angle glaucoma, or diabetes mellitus. Use is explicitly prohibited if taking other paracetamol products or within 14 days of stopping Monoamine Oxidase Inhibitors (MAOIs).
Restricted (Use with Caution)	Individuals with severe hepatic or renal impairment are required to seek professional advice. Caution is also specified for patients with Raynaud’s syndrome, prostatic enlargement, Phenylketonuria (PKU), and those with pre-existing risk factors like chronic alcoholism or being underweight (< 50 kg).

Age and Reproductive Status: The medicine is strictly contraindicated for children under 16 years of age. Use is avoided/not recommended during pregnancy and lactation unless specifically advised by a healthcare professional.

Lemsip Blackcurrant Interactions with other medicines and products

This section describes interactions documented in authoritative government regulatory sources. No usage instructions or therapeutic advice are included.

---

Documented Interaction Constraints

Interaction Type	Interacting Substances and Required Restrictions
Absolute Contraindications	Monoamine Oxidase Inhibitors (MAOIs): Prohibited, including use within 14 days of stopping MAOI therapy. Other Paracetamol-Containing Products: Must not be co-administered. Other Sympathomimetic Decongestants: Co-administration is prohibited.
Pharmacodynamic Risk	Antihypertensives (e.g., Beta-blockers): Phenylephrine may reduce their efficacy, increasing the risk of hypertension. Tricyclic Antidepressants and Cardiac Glycosides (e.g., Digoxin): Increased risk of cardiovascular side effects. Warfarin and other Coumarins: Prolonged regular daily use of Paracetamol may enhance the anticoagulant effect.
Exposure Modification	Absorption Rate Alterations: The speed of Paracetamol absorption may be increased by Metoclopramide or Domperidone or reduced by Cholestyramine.

---

Regulatory-Defined Toxicity and Population Risk

Metabolic and Toxic Potential: Co-administration with Liver Enzyme-Inducing Drugs (e.g., Phenytoin, Carbamazepine, Isoniazid) may increase the hepatotoxic potential of Paracetamol. The consumption of Alcohol must be avoided due to this documented risk.

Population-Specific Notes: The risk of High Anion Gap Metabolic Acidosis upon co-administration of Paracetamol and Flucloxacillin is officially noted, particularly for patients with underlying risk factors such as severe renal impairment, sepsis, malnutrition, or chronic alcoholism.

Central Modulation of Fever and Pain Pathways

This component acts within the central nervous system ( CNS) by inhibiting the synthesis of Prostaglandin E2 ( PGE2), a mediator that influences the body's thermoregulatory set-point in the hypothalamus. This enzyme-mediated inhibition promotes heat dissipation through physiological mechanisms like sweating and vasodilation. Simultaneously, it engages descending pathways in the CNS to reduce the transmission and modulation of nociceptive signaling.

Localized Peripheral Vascular Constriction

The decongestant component acts outside the CNS as a direct agonist of Alpha-1 (alpha1) adrenergic receptors, which are dense in the nasal and sinus mucosa. Activation of these receptors on vascular smooth muscle triggers vasoconstriction. This localized physiological change rapidly reduces the volume of blood pooled in the tissue, decreasing mucosal edema.

Supportive Action on Immune Resilience

The Ascorbic Acid component acts as a systemic antioxidant and enzyme cofactor. Mechanistically, it functions to scavenge reactive oxygen species impacting biological structures, including immune cells, generated by the body's inflammatory response. This supportive function acts as a cofactor for enzymes critical to immune cell function, influencing the overall trajectory of the biological response.

Administration Guidelines for Lemsip Max Cold & Flu Blackcurrant

Instructions for the use of the powder for oral solution include the following.

Administration and Dosing

Lemsip Max Cold & Flu Blackcurrant powder is intended for oral administration as a hot drink. The standard unit dose is the contents of one sachet.

Population	Single Dose	Minimum Dose Interval	Maximum Daily Dose
Adults & Children (16 years and over)	Contents of 1 sachet	4 hours	4 sachets in 24 hours
Children (Under 16 years)	Do not administer	N/A	N/A

The dose may be repeated every 4 to 6 hours as needed.

Preparation and Duration

Preparation Steps:

1. Empty the contents of one sachet into a mug.
2. Fill the mug with hot, but not boiling, water.
3. Stir the solution until the powder is fully dissolved.
4. The drink may be sweetened with sugar or honey if desired.

Duration of Use:

Treatment must be limited to a maximum duration of 5 days. If symptoms do not improve or worsen after this period, the user should consult a healthcare professional. This product should not be taken concurrently with other medicines containing paracetamol.

Research Evidence / Overview of Studies

Summary of Findings: Studies on the Paracetamol and Phenylephrine Combination

Research has explored whether combining paracetamol ( Drug A) and phenylephrine hydrochloride ( Drug B) affects the symptoms of the common cold or influenza. Paracetamol is an established analgesic and antipyretic, and studies have assessed its contribution to the relief of pain, headaches, sore throat, and fever.

The research on phenylephrine focuses on its role as an oral nasal decongestant. While it has been traditionally included in combination products to address nasal swelling, some systematic reviews and recent regulatory assessments have questioned the efficacy of the oral formulation in relieving nasal congestion when compared to a placebo.

Mechanism of Action: Research on Symptom Relief

The paracetamol component is studied for its ability to influence pain and temperature regulation pathways within the central nervous system. The phenylephrine component is investigated for its potential to stimulate adrenergic receptors, which may cause vasoconstriction of small blood vessels in the nasal mucosa, an effect linked to reducing congestion.

Studies examining the combination frequently utilized a dosing period of two to five days, which was associated with the assessed outcomes. Further research is ongoing to fully characterize the specific impact of the combination on biological mechanisms in human participants.

Safety Profile: Overview of Studies on Adverse Events

Research describing the use of this combination has involved thousands of study participants globally. The primary focus of safety research has been on characterizing the incidence of adverse events. Studies have reported on the occurrence of side effects, which were often described as mild and transient, including mild allergic reactions and gastrointestinal discomfort.

Researchers continue to monitor post-marketing data and conduct further long-term studies to develop a comprehensive understanding of the combination's safety profile.

Common questions about Lemsip Blackcurrant (FAQ)

Q: What is the correct way to store my medication?

Official product documents advise storing the medication at a temperature below 30°C. Regulatory guidance further states the product should be kept protected from light and moisture to ensure its stability and effectiveness.

Q: Does it make you sleepy or affect driving?

According to regulatory safety information, this medication has been reported to cause dizziness and somnolence (drowsiness). Regulatory information indicates caution is advised, as these potential effects may impair an individual's ability to drive or operate heavy machinery.

Q: Is it safe to drink alcohol while taking this medicine?

The official product labeling recommends avoiding alcohol consumption while using this medication. Alcohol may increase or worsen certain side effects of the medicine, specifically enhancing feelings of sleepiness or dizziness.

Q: Can children 2 years old use it?

Regulatory documents indicate that the safety and effectiveness of this medication have not been established for its approved uses in children below the age of 12 years. Similarly, the safety profile has not been fully established for adolescents between 12 and 17 years of age.

Q: When is this medication contraindicated (when should I not take it)?

The product information specifies that the medication is contraindicated for individuals with known hypersensitivity (a severe allergic reaction) to the active substance or to any of the other listed ingredients. This information is consistently stated in the official product information section on contraindications.

Q: Is it safe to take long-term?

Official safety data addresses the potential for dependence and misuse, as well as the risks associated with abrupt stopping. Rapid discontinuation of the medication may lead to withdrawal symptoms, which can include anxiety, headache, or insomnia. The medication has been associated with reports of misuse and dependence.

The storage and disposal of this medicine are regulated to maintain product stability and ensure environmental safety.

Official Storage Conditions

Requirement	Official Regulatory Statement
Temperature Limit	Do not store above 25 C
Environmental Protection	Store in a dry place in the original package
Stability Constraint	Do not use after the expiry date (EXP) stated on the packaging
Child Safety	Keep all medicines out of the sight and reach of children

Disposal Instructions

Official labeling mandates that the product should not be disposed of via wastewater or household waste.

To discard unused or expired medicine, users must ask a pharmacist how to dispose of the product. This procedure is required to protect the environment.